Extract to table

Her involvement as Global PI is a significant asset for the CLARION trial, and the publication rights provisions must be evaluated in that context

Second, Veridian has expanded the protocol-deviation exception in carve-out (ii) by inserting language providing that "protocol deviations undertaken in the investigator's reasonable medical judgment for subject safety shall not constitute a basis for withholding indemnification from the Sponsor, regardless of whether such deviation was pre-authorized by the Sponsor

1(f), described as an "academic freedom" provision, which states: "The Sponsor acknowledges and agrees that the investigator's academic freedom to publish and present the results of clinical research is of paramount importance and shall not be abridged by this Agreement

1 are limited to the identification of specifically identified trade secret or patent-sensitive information, and the Sponsor shall not exercise its review rights for the purpose of influencing the scientific content or conclusions of any publication

3 provides that "all multi-center publications arising from the Study shall be coordinated through the Global Principal Investigator, Dr

who shall have primary responsibility for ensuring the scientific integrity, completeness, and accuracy of multi-center publications